Document:

EX-10.1

 Exhibit 10.1 

SECOND AMENDMENT TO THE 

COOPERATION AGREEMENT 

This SECOND AMENDMENT, dated as of December 27, 2022 (this “Amendment”), to the COOPERATION AGREEMENT, dated as of
January 25, 2021 and amended on December 30, 2021 pursuant to the First Amendment (as defined below) (as amended, the “Agreement”), is made by and between HG Vora Capital Management, LLC (“HG Vora”) and
The ODP Corporation, a Delaware corporation (the “Company”). Capitalized terms used but not defined herein shall have the meanings specified in the Agreement. 

WHEREAS, on January 25, 2021, the parties hereto entered into the Agreement; 

WHEREAS, on December 30, 2021, the parties hereto entered into that certain First Amendment to the Agreement (the “First
Amendment”); 
 WHEREAS, pursuant to Section 12 of the Agreement, the Agreement may be amended by an agreement in writing
executed by the parties thereto; and 
 WHEREAS, the parties hereto desire to amend certain terms of the Agreement. 

NOW, THEREFORE, in consideration of and reliance upon the mutual covenants and agreements contained herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 1. Amendments.

 (a) Section 1(a)(ii) of the Agreement is hereby amended and restated in its entirety as follows: 

“(ii) except in the event (A) HG Vora (together with any Affiliates of HG Vora) ceases to own the Company Ownership Level Minimum or
(B) HG Vora has materially breached this Agreement and failed to cure such breach within 5 business days of written notice from the Company to HG Vora specifying any such breach, prior to the 2023 annual meeting of stockholders of the Company
(the “2023 Annual Meeting”), nominate the New Director as one of not more than nine total candidates (or, if greater (to the extent permitted by Section 1(a)(iii) or Section 1(j)
below), the number of candidates equal to the size of the Board as of immediately prior to the 2023 Annual Meeting) for election to the Board at the 2023 Annual Meeting, each having a term expiring at the 2024 annual meeting of stockholders of the
Company (the “2024 Annual Meeting”); provided, however, that as a condition to the Company’s obligation to nominate the New Director for reelection at the 2023 Annual Meeting, the New Director shall (x) be required to
provide the Required Director Information, in each case as promptly as necessary to enable the timely filing of the Company’s proxy statement and other periodic reports with the Securities and Exchange Commission (the “SEC”),
and (y) have complied at all times in all material respects with the Company Policies (as defined below); and” 
  

 (b) Section 1(a)(iii) of the Agreement is hereby amended and restated in its
entirety as follows: 
 “(iii) during the Covered Period, so long as (A) HG Vora (together with any Affiliates of HG Vora) does
not cease to own the Company Ownership Level Minimum and (B) HG Vora has not materially breached this Agreement and failed to cure such breach within 5 business days of written notice from the Company to HG Vora specifying any such breach,
without the prior written consent of HG Vora except to the extent reasonably advisable (as determined in good faith by the Board) in connection with any bona fide settlement or cooperation agreement relating to any actual or threatened contested
solicitation of proxies or consents to vote for the election of directors, the Board shall not increase the size of the Board to more than nine directors (except as permitted by Section 1(j) below).” 

(c) Section 1(b) of the Agreement is hereby amended by replacing each reference to “the 2022 Annual Meeting” with
“the 2023 Annual Meeting”. 
 (d) Section 1(e) of the Agreement is hereby amended and restated in its entirety as
follows: 
 “(e) The New Director shall promptly offer to resign from the Board (and, if requested by the Company, promptly deliver his
or her written resignation to the Board (which shall provide for his or her immediate resignation)) on December 31, 2023, or if earlier, if: (i) HG Vora (together with any Affiliates of HG Vora) ceases to beneficially own the Company
Ownership Level Minimum; (ii) HG Vora otherwise ceases to comply with or breaches any material provision of, this Agreement; or (iii) HG Vora submits a notice of director nominations in connection with the 2024 Annual Meeting. In
furtherance of the foregoing, on December 27, 2022, the New Director executed an irrevocable resignation effective December 31, 2023, in the form attached to this Agreement as Exhibit A (the “Irrevocable Resignation”),
which supersedes the irrevocable resignation, effective December 31, 2022, previously delivered by the New Director to the Board on December 30, 2021 (the “Prior Resignation Letter”). The parties hereto hereby acknowledge
and agree that the Irrevocable Resignation supersedes the Prior Resignation Letter and that the Prior Resignation Letter is deemed void and of no further force or effect.” 

(e) Section 1(f) of the Agreement is hereby amended (i) by replacing each reference to “the 2022 Annual Meeting”
with “the 2023 Annual Meeting”, (ii) by replacing the reference to “the Nominating and Corporate Governance Committee” with “the Corporate Governance and Nominating Committee” and (iii) by replacing all references
to “this Section 1(g)” with “this Section 1(f)”. 

(f) Section 1(h) of the Agreement is hereby amended and restated in its entirety as follows: 

“(h) The term “Covered Period” shall mean the period beginning on the date of this Agreement and continuing until the
earlier of (i) the date that is fourteen days prior to the first day stockholders are eligible to submit stockholder director nominations for the 2024 Annual Meeting pursuant to the Bylaws and (ii) December 31, 2023; provided,
however, that if HG Vora (together with Affiliates of HG Vora) ceases to beneficially own the Company Ownership Level Minimum the Covered Period shall immediately terminate.” 

(g) The Agreement is hereby amended by inserting the following as a new Section 1(i): 

“(i) If at any time between December 31, 2022 and the end of the Covered Period, any current member of the Board (other than the New
Director or the Chief Executive Officer of the Company) does not stand for election at the 2023 Annual Meeting or ceases to be a director, whether as a result of death or incapacity or for any other reason (the “Departing
Director”), and at such time (x) HG Vora (together with any Affiliates of HG Vora) has not ceased to beneficially own at least 9.9% of the Company’s then outstanding shares of Common Stock (excluding any situation where HG Vora
(together with any Affiliates of HG Vora) ceases to own at least 9.9% of the outstanding shares of Common Stock because of 

  
 2 

 
any action of the Company including, without limitation, as the result of a share repurchase or similar Company actions that reduce the number of outstanding shares of Common Stock, the
“Specified Company Ownership Level”) and (y) HG Vora has not materially breached this Agreement and failed to cure such breach within 5 business days of written notice from the Company to HG Vora specifying any such breach, and
(z) there is not more than one nominee of HG Vora on the Board for any reason, including the New Director (including as a result of any increase in the size of the Board in accordance with Section 1(a)(iii) in which HG Vora nominated the
additional director), then HG Vora shall have the right to designate to the Board a substitute person to fill the resulting vacancy (who shall (i) either (A) be a “Partner” or more senior member of HG Vora or (B) qualify as
“independent” pursuant to the rules and regulations of the Nasdaq stock market and applicable rules and regulations of the SEC, (ii) be subject to the approval (such approval not to be unreasonably withheld or delayed) of the
Corporate Governance and Nominating Committee of the Board after consideration in good faith and exercising its fiduciary duties, in accordance with its customary practices for reviewing Board candidates, (iii) have the relevant financial and
business experience to be a director of the Company and (iv) satisfy the publicly disclosed guidelines and policies of the Company with respect to service on the Board) (such person, the “Second Director”). For the avoidance of
doubt, any “Partner” or other more senior investment professional of HG Vora shall be deemed to have the relevant financial and business experience to be a director of the Company. In the event that the Corporate Governance and Nominating
Committee of the Board does not accept (in accordance with the standards set forth herein) a Second Director nominee recommended by HG Vora, HG Vora will have the right to recommend additional Second Director nominees, subject to the terms of this
Section 1(i), for prompt consideration by the Corporate Governance and Nominating Committee. Upon the acceptance of a Second Director nominee by the Corporate Governance and Nominating Committee, the Board will appoint such
Second Director to the Board as promptly as practicable and in any event no later than five business days after the Corporate Governance and Nominating Committee’s recommendation of such Second Director (which recommendation shall be made
promptly after the Corporate Governance and Nominating Committee’s acceptance of such Second Director nominee). The Second Director will thereafter be deemed an additional New Director for purposes of this Agreement and be entitled to the same
rights and be subject to the same requirements under this Agreement that are applicable to the New Director (or any Replacement Director, as applicable), and the Company agrees that the Board will appoint such Second Director to the Board to serve
the unexpired term of the Departing Director. In connection with the foregoing, and as a condition to the Second Director’s appointment to the Board, the Second Director will submit to the Company the Required Director Information and, prior to
his or her appointment to the Board, the Second Director shall, and HG Vora shall cause the Second Director to, execute an irrevocable resignation in the form of the Irrevocable Resignation (substituting the name of the Second Director for the name
of the New Director therein). Following the appointment of a Second Director to replace a Departing Director in accordance with this Section 1(i), all references to the New Director herein shall be deemed to include the
Second Director, mutatis mutandis (it being understood that this sentence shall apply whether or not references to the New Director expressly state that they include the Second Director), provided, that, (x) with respect to the
Second Director, all references to the Company Ownership Level Minimum herein shall instead be deemed to refer to the Specified Company Ownership Level (including, for the avoidance of doubt, with respect to the obligation of the Second Director to
resign pursuant to Section 1(e)(i)) and (y) all references to the New Director in Section 1(g) shall instead be deemed to refer to “one or more New Directors”. Notwithstanding anything to the contrary in
this Agreement, if at any time (x) HG Vora (together with any Affiliates of HG Vora) ceases to beneficially own the Specified Company Ownership Level or (y) HG Vora has materially breached this Agreement and failed to cure such breach
within 5 business days of written notice from the Company to HG Vora specifying any such breach, HG Vora’s rights pursuant to this Section 1(i) shall automatically terminate. Notwithstanding anything to the contrary in
this Agreement, HG Vora shall only have the right to designate one Second Director, and in the event there are multiple Departing Directors prior to the end of the Covered Period or the termination of this Agreement, this
Section 1(i) shall not apply to any Departing Directors following the first such Departing Director.” 

  
 3 

 (h) The Agreement is hereby amended by inserting the following as a new
Section 1(j): 
 “(j) Following the time that HG Vora shall be entitled to designate a Second Director to the Board pursuant to
Section 1(i), notwithstanding anything to the contrary in this Agreement, the Board may increase the size of the Board to no more than ten directors (and fill the resulting vacancy) without the consent of HG Vora.”

 (i) Section 2(a)(i) of the Agreement is hereby amended by replacing the reference to “the 2022 Annual Meeting”
with “the 2023 Annual Meeting”. 
 (j) Section 10(a) of the Agreement is hereby amended by replacing the phrase
“the confidentiality agreement, dated as of the date hereof, between the Company and HG Vora (the “Confidentiality Agreement”)” with “the confidentiality agreement, dated as of the date hereof, between the Company and
HG Vora (as amended on December 30, 2021 and December 27, 2022, and as it may be further amended, restated, supplemented or otherwise modified from time to time in accordance with its terms, the “Confidentiality
Agreement”)”. 
 (k) Section 15(a) of the Agreement is hereby amended by replacing the reference to “the
2022 Annual Meeting” with “the 2023 Annual Meeting”. 
 (l) Exhibit A to the Agreement is hereby amended and
restated in its entirety as set forth in Annex I to this Amendment. 
 2. Representations of HG Vora. HG Vora represents and warrants
that, as of the date hereof, the representations and warranties of HG Vora in Section 5(d) and Section 5(e) of the Agreement are true and correct, substituting the date of this Amendment for any references to the date of the Agreement
therein. 
 3. Miscellaneous. The terms and provisions of Sections 11, 12, 13, 14, 16, 17 and 18 of the Agreement shall apply
mutatis mutandis to this Amendment. 
 4. Effect of Amendment. Except as set forth herein, the Agreement shall remain
unchanged and in full force and effect. 
 [Signature Pages Follow] 

  
 4 

 IN WITNESS WHEREOF, each of the parties hereto has executed this Amendment or caused the
same to be executed by its duly authorized representative as of the date first above written. 
  

			
	THE ODP CORPORATION
		
	By:	 	 /s/ Sarah E. Hlavinka

		 	Name: Sarah E. Hlavinka
		 	Title: Executive Vice President, Chief Legal Officer and Corporate Secretary

 [Signature Page to Second Amendment to the Cooperation Agreement] 

 IN WITNESS WHEREOF, each of the parties hereto has executed this Amendment or caused the
same to be executed by its duly authorized representative as of the date first above written. 
  

			
	HG VORA CAPITAL MANAGEMENT, LLC
		
	By:	 	 /s/ Parag Vora

		 	Name: Parag Vora
		 	Title: Manager

 [Signature Page to Second Amendment to the Cooperation Agreement] 

 ANNEX I 

Exhibit A 
 IRREVOCABLE
RESIGNATION 
 December 27, 2022 
 Board of Directors 

The ODP Corporation 
 6600 North Military Trail 

Boca Raton, FL 33496 
 Re: Irrevocable Resignation 

Ladies and Gentlemen: 
 This irrevocable
resignation is delivered pursuant to that certain Cooperation Agreement, dated as of January 25, 2021, between The ODP Corporation (the “Company”) and HG Vora Capital Management, LLC (“HG Vora”), as amended on
December 30, 2021 and December 27, 2022 (the “Agreement”). Capitalized terms used herein but not defined shall have the meaning set forth in the Agreement. 

Reference is hereby made to the irrevocable resignation delivered by the undersigned to the Board on December 30, 2021 (the
“Prior Resignation Letter”). In accordance with Section 1(e) of the Agreement, this irrevocable resignation supersedes the Prior Resignation Letter and the Prior Resignation Letter is void and of no further force or effect.

 Pursuant to Section 1(e) of the Agreement, effective only upon, and subject to, the earliest of (i) such time as HG Vora
(together with any Affiliates of HG Vora) ceases collectively to beneficially own (as defined in Rule 13d-3 (as in effect from time to time) promulgated by the SEC under the Exchange Act) the Company Ownership
Level Minimum, (ii) such time as HG Vora otherwise ceases to comply with or breaches any material provision of the Agreement, (iii) such time as HG Vora submits a notice of director nominations in connection with the 2024 Annual Meeting
and (iv) December 31, 2023, I hereby irrevocably resign from my position as a director of the Company and from any and all committees of the Board on which I serve. 

[Signature Page Follows] 

	
	Sincerely,
	
	          

	Marcus Dunlop

 [Signature Page to Irrevocable Resignation]EX-4.4

 Exhibit 4.4 

FORM OF ASSIGNMENT, ASSUMPTION AND AMENDMENT TO WARRANT AGREEMENT 

THIS ASSIGNMENT, ASSUMPTION and AMENDMENT TO WARRANT AGREEMENT (this “Amendment”) is made and entered into as of
[                            ], by and among (i) Lionheart III Corp, a Delaware
corporation (the “SPAC”), (ii) SMX Public Limited Company (f/k/a Empatan Public Limited Company), a public limited company incorporated under the laws of Ireland (the “Company”), and
(iii) Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (the “Agent”). Capitalized terms used but not otherwise defined herein shall have
the respective meanings assigned to such terms in the Warrant Agreement (as defined below) (and if such term is not defined in the Warrant Agreement, then the Business Combination Agreement (as defined below)). 

RECITALS 
 WHEREAS,
SPAC and the Agent are parties to that certain Warrant Agreement, dated as of November 3, 2021 (as amended, including without limitation by this Amendment, the “Warrant Agreement”), pursuant to which the Agent agreed to
act as the SPAC’s warrant agent with respect to the issuance, registration, transfer, exchange, redemption and exercise of (i) warrants to purchase SPAC Class A Common Shares underlying the units of the SPAC issued in SPAC’s
initial public offering (“IPO”) (the “Public Warrants”), (ii) warrants to purchase SPAC Class A Common Shares underlying the units of SPAC acquired by Lionheart Equities, LLC (the
“Sponsor”), in a private placement concurrent with the IPO (the “Sponsor Private Warrants”), (iii) warrants to purchase SPAC Class A Common Shares underlying the units of the Company acquired by
Nomura Securities International, Inc., Northland Securities, Inc. and Drexel Hamilton, LLC, in a private placement concurrent with the IPO (the “Underwriter Underlying Warrants” and, the Underwriter Underlying Warrants
together with the Sponsor Private Warrants, the “Private Warrants”), (iv) warrants to purchase SPAC Class A Common Shares underlying the units of SPAC issuable to the Sponsor or an affiliate of the Sponsor or
certain officers and directors of SPAC upon conversion of up to $1,500,000 of working capital loans (the “Working Capital Warrants”), and (v) all other warrants issued by SPAC after the IPO, in connection with or
following the Business Combination (the “Post-IPO Warrants” and together with the Public Warrants, the Private Warrants, and the Working Capital Warrants, the
“Warrants”); 
 WHEREAS, (i) SPAC, (ii) the Company, (iii) Security Matters Limited, an
Australian public company with Australian Company Number (ACN) 626 192 998 listed on the Australian Stock Exchange, and (iv) Aryeh Merger Sub, Inc. (“Merger Sub”), a Delaware corporation and a wholly owned subsidiary of
the Company, are parties to that certain Business Combination Agreement, dated as of July 26, 2022 (as it may be amended from time to time in accordance with the terms thereof, the “Business Combination Agreement”); 

WHEREAS, pursuant to the Business Combination Agreement, upon the consummation of the transactions contemplated thereby (the
“Closing”), among other matters and subject to the terms and conditions thereof, Merger Sub will merge with and into SPAC, with SPAC continuing as the surviving entity (the “Merger” and together with
the other transactions contemplated by the Business Combination Agreement, the “Transactions”), and as a result of which, among other matters, (i) SPAC shall become a wholly-owned subsidiary of the Company,
(ii) each issued and outstanding SPAC Class A Common Share immediately prior to the SPAC Merger Effective Time shall no longer be outstanding and shall automatically be cancelled, in exchange for one (1) validly issued, fully paid and
non-assessable Company Ordinary Share (as defined below), and (iii) each issued and outstanding SPAC Class B Common Share immediately prior to the SPAC Merger Effective Time shall no longer be
outstanding and shall automatically be cancelled, in exchange for one (1) validly issued, fully paid and non-assessable Company Ordinary Share all upon the terms and subject to the conditions set forth in
the Business Combination Agreement and in accordance with the provisions of applicable law; 

 WHEREAS, upon consummation of the Merger, as contemplated by Section 4.4 of the
Warrant Agreement, each of the issued and outstanding Warrants shall remain outstanding and be automatically adjusted, as a result of which the outstanding Warrants will no longer be exercisable for SPAC Class A Common Shares but instead will
be exercisable (subject to the terms and conditions of the Warrant Agreement as amended hereby) for the same number of Company Ordinary Shares at the same exercise price per share; and 

WHEREAS, all references to “Class A common stock” or “Common Stock” in the Warrant Agreement (including all
Exhibits thereto) shall mean ordinary shares, par value $0.0001 per share, of the Company (together with any other securities of the Company or any successor entity issued in consideration of (including as a stock split, dividend or distribution) or
in exchange for any of such securities, “Company Ordinary Shares”); 
 WHEREAS, the board of directors of
SPAC has determined that the consummation of the transactions contemplated by the Business Combination Agreement will constitute a Business Combination (as defined in the Warrant Agreement); and 

WHEREAS, in connection with and pursuant to the Merger, the Warrant Agreement (as amended hereby) shall be assigned to the Company, and
the Company shall assume all the liabilities and obligations of SPAC under the Warrant Agreement with the same force and effect as if the Company were initially a party to the Warrant Agreement. 

NOW, THEREFORE, in consideration of the premises and the mutual promises herein made, and in consideration of the representations,
warranties and covenants herein contained, and intending to be legally bound hereby, the parties hereto agree as follows: 

1.    Assignment and Assumption; Consent. 

(a)    Assignment and Assumption. Pursuant to the Merger, the parties hereby acknowledge the automatic assignment
of the Warrant Agreement and the Warrants (each as amended hereby) to the Company as of the SPAC Merger Effective Time and the automatic assumption by the Company of all of SPAC’s liabilities and obligations under the Warrant Agreement and the
Warrants (each as amended hereby) arising from and after the SPAC Merger Effective Time with the same force and effect as if the Company were initially a party to the Warrant Agreement. 

(b)    Consent. The Agent hereby consents to the assignment of the Warrant Agreement and the Warrants by SPAC to
the Company and the assumption by the Company of the SPAC’s obligations under the Warrant Agreement pursuant to Section 1.1 hereof effective as of the SPAC Merger Effective Time, the assumption of the Warrant
Agreement and Warrants by the Company from SPAC pursuant to Section 1.1 hereof effective as of the SPAC Merger Effective Time, and to the continuation of the Warrant Agreement and Warrants in full force and effect
from and after the SPAC Merger Effective Time, subject at all times to the Warrant Agreement and Warrants (each as amended hereby) and to all of the provisions, covenants, agreements, terms and conditions of the Warrant Agreement and this Agreement.

 2.    Amendments to Warrant Agreement. The parties hereto hereby agree to the following amendments to the
Warrant Agreement: 
 (a)    Defined Terms. The defined terms in this Amendment, including in the preamble and
recitals hereto, and the definitions incorporated by reference from the Business Combination Agreement, are hereby added to the Warrant Agreement as if they were set forth therein.

  
 2 

 (b)    Preamble. The preamble of the Warrant Agreement is hereby
amended by deleting “Lionheart III Corp, a Delaware corporation” and replacing it with “SMX Public Limited Company, a public limited company incorporated under the laws of Ireland”. As a result thereof, all references to the
“Company” in the Warrant Agreement shall be amended such that they refer to the Company rather than SPAC. 

(c)    Reference to Company Ordinary Shares. All references to “Class A common stock” or
“Common Stock” in the Warrant Agreement (including all Exhibits thereto) shall mean Company Ordinary Shares. 

(d)    Notices. Section 9.2 of the Warrant Agreement is hereby amended to delete the address of the Company
for notices under the Warrant Agreement and instead add the following address for notices to Company: 
  

			
	 If to the Company to:

 
 SMX Public Limited Company

 
 c/- Afik & Co.

103 Hahasmonaim St.
 Tel
Aviv 6120101, Israel
 Attention: Haggai Alon, CEO
 Email:
info@securitymattersltd.com
	  	 with a copy (which will not constitute notice) to:

 
 Afik & Co.

103 Hahasmonaim St.
 Tel Aviv 6120101, Israel

Attention: Doron Afik
 Email: doron@afiklaw.com

  3.    Stamp Duty. A new section 5.7 is hereby inserted into the Warrant
Agreement as follows: 
 “5.7 Stamp Duty. Notwithstanding the provisions prejudice to Section 5.1, Irish Holdco may require,
as a condition to the registration of any transfer of a Warrant, evidence from the transferor or intended transferee, which is satisfactory to the Company, that any Irish stamp duty liability arising on such transfer has been duly paid (and any
instrument of transfer, as the case may be, has been duly stamped for Irish stamp duty purposes) or that the proposed transfer is otherwise exempt from such duty. The Company, at its absolute discretion, may, or may procure that one of its
subsidiaries shall, pay any Irish stamp duty arising on a transfer of Warrants on behalf of the transferee of such Warrants. If stamp duty resulting from the transfer of Warrants in the Company which would otherwise be payable by the transferee is
paid by the Company or any subsidiary of the Company on behalf of the transferee, then in those circumstances, the Company shall, on its behalf or on behalf of its subsidiary (as the case may be), be entitled to (i) reimbursement of the stamp
duty from the transferee, (ii) set-off the stamp duty against any dividends payable by the Company to the transferee of those Warrants and (iii) to the extent permitted by section 1042 of the
Companies Act 2014 of Ireland, as amended, and every statutory modification and re-enactment thereof for the time being, claim a first and paramount lien on the Warrants (or Company Ordinary Shares issued upon
the exercise of Warrants) on which stamp duty has been paid by the Company or its subsidiary for the amount of stamp duty paid. The Company’s lien shall extend to all dividends paid on Company Ordinary Shares issued upon the exercise of such
Warrants.” 
 4.    Effectiveness. Notwithstanding anything to the contrary contained herein, this Amendment
shall only become effective upon the Closing. In the event that the Business Combination Agreement is terminated in accordance with its terms prior to the Closing, this Amendment and all rights and obligations of the parties hereunder shall
automatically terminate and be of no further force or effect. 

  
 3 

 5.    Miscellaneous. Except as expressly provided in this
Amendment, all of the terms and provisions in the Warrant Agreement are and shall remain in full force and effect, on the terms and subject to the conditions set forth therein. This Amendment does not constitute, directly or by implication, an
amendment or waiver of any provision of the Warrant Agreement, or any other right, remedy, power or privilege of any party thereto, except as expressly set forth herein. Any reference to the Warrant Agreement in the Warrant Agreement or any other
agreement, document, instrument or certificate entered into or issued in connection therewith, shall hereinafter mean the Warrant Agreement as the case may be, as amended by this Amendment (or as such agreement may be further amended or modified in
accordance with the terms thereof). The terms of this Amendment shall be governed by, enforced and construed and interpreted in a manner consistent with the provisions of the Warrant Agreement, as it applies to the amendments to the Warrant
Agreement herein, including without limitation Section 9 of the Warrant Agreement. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK;
SIGNATURE PAGES FOLLOW] 

  
 4 

 IN WITNESS WHEREOF, each party hereto has caused this Amendment to Warrant Agreement
to be signed and delivered by its respective duly authorized officer as of the date first above written. 
  

			
	 SPAC:
  

LIONHEART III CORP

		
	By:	 	 
		 	Name:
		 	Title:

  

			
	 The Company:
  

SMX PUBLIC LIMITED COMPANY

		
	By:	 	 
		 	Name:
		 	Title:

  

			
	 Agent:
  

CONTINENTAL STOCK TRANSFER & TRUST COMPANY

		
	By:	 	 
		 	Name:
		 	Title:

 [Signature Page to Amendment to Warrant Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]